These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2597314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
    Fornstedt B, Carlsson A.
    Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
    [Abstract] [Full Text] [Related]

  • 4. Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.
    Zhang F, Dryhurst G.
    J Med Chem; 1994 Apr 15; 37(8):1084-98. PubMed ID: 7909337
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H, Jonsson G.
    Med Biol; 1984 Apr 15; 62(3):198-209. PubMed ID: 6492900
    [Abstract] [Full Text] [Related]

  • 8. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
    Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B.
    J Neurochem; 1998 Nov 28; 71(5):2112-22. PubMed ID: 9798937
    [Abstract] [Full Text] [Related]

  • 12. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
    Fornstedt B, Rosengren E, Carlsson A.
    Neuropharmacology; 1986 Apr 28; 25(4):451-4. PubMed ID: 3086766
    [Abstract] [Full Text] [Related]

  • 13. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H, Carlsson A.
    J Neurochem; 1987 Sep 28; 49(3):959-67. PubMed ID: 3612134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
    Goldstein DS, Holmes C, Sullivan P, Jinsmaa Y, Kopin IJ, Sharabi Y.
    Parkinsonism Relat Disord; 2016 Oct 28; 31():79-86. PubMed ID: 27474472
    [Abstract] [Full Text] [Related]

  • 17. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA, Cass WA, Huettl P, Brock S, Zhang Z, Gash DM.
    Brain Res; 1999 Jan 30; 817(1-2):163-71. PubMed ID: 9889359
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence that the substantia nigra is a site of action for L-DOPA.
    Robertson GS, Robertson HA.
    Neurosci Lett; 1988 Jun 29; 89(2):204-8. PubMed ID: 3393296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.